HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Newly Public Physicians Formula Links 2006 Growth To Expansion In Masstige

This article was originally published in The Rose Sheet

Executive Summary

Physicians Formula's penetration of the U.S. masstige channel in 2006 drove total revenue up 21 percent to $95.4 million for the fiscal year, the company reported during a March 12 year-end earnings call

You may also be interested in...



Physicians Formula Looks To Capitalize On Natural Cosmetics Trend In 2008

Physicians Formula's Organic Wear cosmetic collection could represent more than 30 percent of the company's product portfolio by 2010, CEO Ingrid Jackel said during a third-quarter analyst call Nov. 18

Physicians Formula Looks To Capitalize On Natural Cosmetics Trend In 2008

Physicians Formula's Organic Wear cosmetic collection could represent more than 30 percent of the company's product portfolio by 2010, CEO Ingrid Jackel said during a third-quarter analyst call Nov. 18

Catterton Partners/Chrysallis Discusses Future Of Nia 24, Fekkai Investments

Chrysallis's Canyon Ranch skin-care range will launch in spring 2008; meanwhile, the company is preparing to launch the first body product within its Nia 24 line, formulated to address moderate to severe sun damage, and to expand Fekkai hair care to new product categories, the firm says

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014598

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel